- S&P 500 and the Nasdaq hit fresh ATH
- Jobless claims fell more than expected
- Roku (ROKU.US) stock fell sharply after mixed quarterly figures
US indices launched today's session higher with both the S&P 500 and the Nasdaq hit fresh record highs while the Dow Jones hovered near records following yesterday's comments from the Federal Reserve. The Central Bank announced an expected reduction in stimulus and signaled no hurry to raise interest rates while reiterating inflationary pressures are likely to be transitory. On the data front, the number of Americans filing new claims for unemployment benefits dropped to 269k in the week ending October 30th, which is a new pandemic low, from a revised 283k in the previous period and below analysts' projections of 275k.
US100 hit new all-time high at 16,227 pts yesterday following FOMC decision and is currently testing upper limit of the ascending channel which coincides with 127.2% Fibonacci external retracement of the last downward wave. If sellers will manage to halt advances here, then another downward impulse towards major support at 15,750 pts may be launched. Source: xStation5
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appCompany news:
Roku (ROKU.US) stock plunged nearly 8.0% in premarket trading after the video-streaming device maker reported mixed quarterly figures. Company earned 48 cents per share, well above analysts' estimates of 6-cents per share, however revenue fell short of forecasts and the company issued a lower-than-expected guidance for the current quarter.
Roku (ROKU.US) stock launched today’s session and is testing major support at $290.00. If current sentiment prevails, then downward move may accelerate towards next support at $221.00 which coincides with 61.8% Fibonacci retracement of the upward wave launched in March 2020. Source: xStation5
Etsy (ETSY.US) stock fell 0.70% in premarket after the online crafts marketplace issued weaker-than-expected current-quarter revenue guidance although it did beat forecasts for its most recent quarter, coming in 8 cents above estimates with earnings of 62 cents per share.
Moderna (MRNA.US) stock plunged more than 12.0% in premarket, following quarterly shortfalls in both earnings and revenue as well as a cut in the drug maker's full-year earnings outlook.
IBM (IBM.US) shares fell over 3.0% after the tech giant completed the spin-off of its IT services section, around 25% of its overall business, in a battle to arrest a decade of decline.
Regeneron Pharmaceuticals (REGN.US) stock rose nearly 2.7% before the opening bell after the company posted upbeat quarterly results. Regeneron earned an adjusted $15.37 per share, beating analysts' estimates of $10.10, boosted by strong sales of its drugs, including its Covid-19 antibody offering as well as other treatments.